| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.700 | None | 1.000 | 0 | 0 | 1997 | 2020 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.620 | None | 1.000 | 0 | 0 | 2003 | 2018 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.620 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2001 | 2016 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1983 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1997 | 2020 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.470 | None | 1.000 | 0 | 0 | 2007 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.470 | None | 1.000 | 0 | 0 | 2002 | 2019 | |||||||||
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.460 | None | 1.000 | 0 | 0 | 2006 | 2019 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
disease | 0.450 | None | 1.000 | 0 | 0 | 2010 | 2018 | ||||||||
|
presenilin 1 | 0.469 | 0.846 | 0.97 |
|
disease | 0.440 | None | 1.000 | 0 | 0 | 2000 | 2018 | ||||||||
|
period circadian regulator 3 | 0.559 | 0.731 | 1.4E-17 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2009 | 2018 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2006 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta3 | 0.546 | 0.615 | 0.95 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2001 | 2012 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
disease | 0.420 | None | 0.667 | 0 | 0 | 2000 | 2005 | ||||||||
|
huntingtin | 0.548 | 0.654 | 1.00 |
|
disease | 0.420 | None | 1.000 | 0 | 0 | 2004 | 2017 | ||||||||
|
dual specificity phosphatase 6 | 0.511 | 0.846 | 0.98 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2005 | 2005 | ||||||||
|
fibroblast growth factor 17 | 0.593 | 0.692 | 0.96 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2009 | 2009 | ||||||||
|
sarcoglycan epsilon | 0.626 | 0.538 | 2.4E-02 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
granulin precursor | 0.435 | 0.846 | 7.0E-02 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2010 | 2012 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 3 | 0.544 | 0.615 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 2008 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 2016 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 2001 | 2019 |